These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 23810251)
21. Values for preventing influenza-related morbidity and vaccine adverse events in children. Prosser LA; Bridges CB; Uyeki TM; Rêgo VH; Ray GT; Meltzer MI; Schwartz B; Thompson WW; Fukuda K; Lieu TA Health Qual Life Outcomes; 2005 Mar; 3():18. PubMed ID: 15780143 [TBL] [Abstract][Full Text] [Related]
22. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H; Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307 [TBL] [Abstract][Full Text] [Related]
23. Comparison of alpha-spending plans for near real-time monitoring for Guillain-Barré Syndrome after influenza vaccination during the 2010/11 influenza season. Sandhu SK; Hua W; MaCurdy TE; Franks RL; Avagyan A; Chillarige Y; Wernecke M; Kelman J; Ball R Vaccine; 2020 Feb; 38(9):2221-2228. PubMed ID: 31932134 [TBL] [Abstract][Full Text] [Related]
24. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination. Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755 [TBL] [Abstract][Full Text] [Related]
25. Neurologic complications associated with influenza vaccination: two adult cases. Nakamura N; Nokura K; Zettsu T; Koga H; Tachi M; Terada M; Katoh H; Itoh Y; Osawa H; Ozeki T; Yamamoto H Intern Med; 2003 Feb; 42(2):191-4. PubMed ID: 12636241 [TBL] [Abstract][Full Text] [Related]
26. Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy. Stowe J; Andrews N; Miller E CNS Drugs; 2020 Jan; 34(1):1-8. PubMed ID: 31576507 [TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Choe YJ; Cho H; Bae GR; Lee JK Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684 [TBL] [Abstract][Full Text] [Related]
29. Guillain-Barre syndrome after influenza vaccine administration: two adult cases. Bedard Marrero V; Osorio Figueroa RL; Vázquez Torres O Bol Asoc Med P R; 2010; 102(2):39-41. PubMed ID: 20939203 [TBL] [Abstract][Full Text] [Related]
30. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far]. Press R; Andersen O Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249 [No Abstract] [Full Text] [Related]
31. Influenza vaccination and Guillain Barré syndrome. Haber P; DeStefano F Clin Immunol; 2003 Dec; 109(3):359; author reply 360-1. PubMed ID: 14697752 [No Abstract] [Full Text] [Related]
32. Pandemic (H1N1) 2009 influenza. Polkinghorne B; Ward K; Totaro R N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344 [No Abstract] [Full Text] [Related]
35. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Stowe J; Andrews N; Wise L; Miller E Am J Epidemiol; 2009 Feb; 169(3):382-8. PubMed ID: 19033158 [TBL] [Abstract][Full Text] [Related]
36. Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010. Mayet A; Ligier C; Gache K; Manet G; Nivoix P; Dia A; Haus-Cheymol R; Verret C; Duron S; Faure N; Piarroux M; De Laval F; Simon F; Decam C; Chaudet H; Meynard JB; Rapp C; Deparis X; Migliani R Vaccine; 2011 Mar; 29(14):2576-81. PubMed ID: 21296693 [TBL] [Abstract][Full Text] [Related]
37. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea. Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315 [TBL] [Abstract][Full Text] [Related]
38. Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004. Haber P; Slade B; Iskander J Vaccine; 2007 Nov; 25(48):8101. PubMed ID: 17933441 [No Abstract] [Full Text] [Related]
39. Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barré syndrome. Hawken S; Kwong JC; Deeks SL; Crowcroft NS; McGeer AJ; Ducharme R; Campitelli MA; Coyle D; Wilson K Emerg Infect Dis; 2015 Feb; 21(2):224-31. PubMed ID: 25625590 [TBL] [Abstract][Full Text] [Related]
40. Predictive value of surveillance case definitions of Guillain-Barré Syndrome in vaccine safety assessment. MSMR; 2012 Mar; 19(3):8-9. PubMed ID: 22452715 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]